STEPS Implementation Trial
Part of paid clinical trials in Tuscaloosa, Alabama.
- Sponsor
- University of Alabama, Tuscaloosa
- Study ID
- NCT05695885
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 16 Years - 25 Years
- Healthy Volunteers
- Accepted
Interventions
- STEPS — BEHAVIORALbehavioral counseling
- Services as usual (SAU) — BEHAVIORALbehavioral counseling normally provided
Study Details
This study will inform understanding of how to support emerging adults with autism spectrum disorder (ASD). The investigators will use a theoretically informed and research-based transition support program developed for people with ASD and test how effective it is when delivered by community agencies. Results will provide information on the effectiveness of the program as well as on mechanisms of change and contextual factors that promote or impede implementation.
Key Dates
- Start date
- Apr 1, 2023
- Status verified
- Aug 2024
- Primary completion
- Mar 31, 2025
- Completion
- Dec 31, 2025
Study Design
- Enrollment
- 80 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Experimental: STEPS14 session counseling targeting adult independence skills
- Other: ControlServices as usual
Primary Outcome Measure
Transition Readiness Scale-Revised [ Time Frame: 30 days ]
Central Contacts
- Susan W White, PhD2053481967
- Nicole Powell, PHD2053483535
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Center o=for Youth Development and Intervention | Tuscaloosa | Alabama | 35487 |
Find similar trials in Tuscaloosa, AL
By condition
By specialty
By research site
Related Studies
- ML-004 Open-Label Extension Study in Adults and Adolescents With Autism Spectrum Disorders (ASD)PHASE2 · Enrolling By Invitation · MapLight Therapeutics · Dothan, Alabama
- Comparing Two Different Emotion Therapies for Autistic Youth and Young AdultsRecruiting · University of Pittsburgh · Tuscaloosa, Alabama
- Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD)PHASE2 · Recruiting · Montefiore Medical Center · New York, New York
- Cerebellar Stimulation and Cognitive ControlRecruiting · Krystal Parker, PhD · Iowa City, Iowa